Predictive and prognostic biomarkers in breast tumours Review


Authors: Krystel-Whittemore, M.; Tan, P. H.; Wen, H. Y.
Review Title: Predictive and prognostic biomarkers in breast tumours
Abstract: In the age of precision medicine, extensive research has investigated tumour biomarkers to predict the behaviour of cancer and/or response to treatment in order to better understand the prognosis and treatment of disease. In breast cancer, significant progress has been made to categorise a common disease into subtypes defined by intrinsic tumour biology, measured by tumour biomarkers. This review encompasses the established biomarkers within breast cancer with the most up-to-date information regarding their understanding and clinical use as predictive and/or prognostic markers of breast cancer. © 2023 Royal College of Pathologists of Australasia
Keywords: missense mutation; review; ki 67 antigen; breast cancer; estrogen responsive element; food and drug administration; pathology; breast neoplasms; tumor marker; gene rearrangement; microsatellite instability; breast tumor; hormonal therapy; neoadjuvant chemotherapy; estrogen receptor; progesterone receptor; ligand binding; differentiation; personalized medicine; molecular pathology; chromosome 14; cancer prognosis; breast pathology; invasive breast cancer; humans; prognosis; human; female; pembrolizumab; hormone receptor positive breast cancer; biomarkers, tumor; breast tissue; trastuzumab deruxtecan; neoplastic cell transformation; breast biomarkers; breast clinical oncology
Journal Title: Pathology
Volume: 56
Issue: 2
ISSN: 0031-3025
Publisher: Royal College of Pathologists of Australasia  
Date Published: 2024-03-01
Start Page: 186
End Page: 191
Language: English
DOI: 10.1016/j.pathol.2023.10.014
PUBMED: 38212230
PROVIDER: scopus
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hannah Yong Wen
    301 Wen